At Orphalan we identify, develop and provide access to innovative treatments for patients with rare diseases.
At Orphalan we strive to develop rare disease treatments to improve patients' lives
At Orphalan we identify, develop, and provide access to innovative treatments for patients with rare diseases to make a positive and meaningful difference. We work together by, listening to patients and putting them first, enables us to provide treatments and services that work for them.
We use a global network of experts including scientists, academic institutions and companies with innovative technologies to provide support to patients.
At Orphalan we continuously invest in research and development, actively exploring novel drug options to treat a range of devastating rare diseases.
Our goal is for patients to receive the best treatment possible by developing comprehensive research and development programs, delivering educational programs to patients and physicians.
At Orphalan we offer the following approach:
- Putting patients at the core of everything we do
- A primary focus on rare, often fatal diseases where current therapeutic options do not exist, are suboptimal, or are associated with severe complications
- Evidence based treatments: All our treatments are backed by data driven generation of scientific evidence.
- Successful commercial and regulatory implementation of treatments across multiple markets
We drive our business forward by sharing the same core values:
Find out more about Orphalan, who we are and what we do
Our research and development strategy is focused on the patient
Find out more about Orphalan and get in touch.